Cargando…
Antibody disulfide bond reduction during process development: Insights using a scale-down model process
Autores principales: | Ruaudel, Julie, Bertschinger, Martin, Letestu, Sonia, Giovannini, Roberto, Wassmann, Paul, Moretti, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685413/ http://dx.doi.org/10.1186/1753-6561-9-S9-P24 |
Ejemplares similares
-
Effects of antibody disulfide bond reduction on purification process performance and final drug substance stability
por: Chung, Wai Keen, et al.
Publicado: (2017) -
Reduction of disulfide bonds during antigen processing: evidence from a thiol-dependent insulin determinant
Publicado: (1991) -
The impact of thioredoxin reduction of allosteric disulfide bonds on the therapeutic potential of monoclonal antibodies
por: Gurjar, Shalom A., et al.
Publicado: (2019) -
Untargeted proteomics reveals upregulation of stress response pathways during CHO-based monoclonal antibody manufacturing process leading to disulfide bond reduction
por: Park, Seo-Young, et al.
Publicado: (2021) -
BEAT(® )the bispecific challenge: a novel and efficient platform for the expression of bispecific IgGs
por: Moretti, Pierre, et al.
Publicado: (2013)